VIZIENT, INC. for VIZIENT INC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Group Purchasing - Conducted education and outreach efforts about the value hospital group purchasing organizations deliver the U.S. health care system. Drug Pricing - Supported The Lower Drug Costs through Competition Act (H.R. 749), The Fair Access to Safe and Timely Generics Act (H.R. 2051), The Preserving Access to Affordable Generics (S.124), The Increasing Competition in Pharmaceuticals Act (S.297) and the CREATES Act (S. 974). Engaged and monitored draft legislation to modify the 340B drug discount program. Supported passage of H.R. 4392. Opposed H.R. 4710. Supported efforts to stabilize ACA insurance markets - including continuing funding for cost-sharing reduction subsidies and other efforts to stabilize insurance markets. Supported passage of the Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act (S.870). Independent Payment Advisory Board (H.R. 859, S. 251) - Supported passage of legislation to repeal IPAB. Preventive Health Savings Act (H.R. 2953) - Supported passage of legislation to allow for Congressional Budget Office to estimate cost-savings from preventive health care services. Supported House passage of the Protecting Access to Care Act (H.R. 1215) and the Saving Lives, Saving Costs Act (H.R. 1565).
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHELSEA ARNONE | — |
| SHOSHANA KRILOW | — |
| STEVEN RIXEN | — |
Taxation/Internal Revenue Code TAX
H.R. 1 - The Tax Reform and Jobs Act - monitored development and passage of H.R. 1. Opposed provisions to end the penalty for the ACA's individual mandate. Opposed proposals that would negatively impact tax-exempt financing by ending the ability of nonprofit hospitals to utilize private activity bond financing and advance refunding. Hospital Tax Exemption and Community Benefit - Monitored tax reform proposals for potential changes to hospital community benefit requirements to maintain tax exemption.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHELSEA ARNONE | — |
| SHOSHANA KRILOW | — |
| STEVEN RIXEN | — |
Medicare/Medicaid MMM
340B Drug Discount Program - Opposed Medicare reimbursement reductions for hospitals eligible for the 340B drug discount program. Supported passage of H.R. 4392. Opposed H.R. 4710. Children's Health Insurance Program (H.R. 3922, Championing Healthy Kids Act) - Supported passing legislation to extend the Children's Health Insurance Program. Medicaid Disproportionate Share Hospital (DSH) Payments - Supported legislation (H.R. 3922) delaying implementation of Medicaid DSH payment cuts. Urged Congress to pass legislation to continue Medicare "extenders" (Medicare Dependent Hospital program, Low Volume Adjustment and ambulance add-on payments). Supported passage of the ACE Kids Act (S.428). Home Infusion Payments (S. 1738, H.R. 3178) - Supported making changes to align the effective dates of ASP reimbursement for Part B DME infusion drugs and infusion services payments. Medicare Site-neutral Payment Policies- Monitored proposals to reduce hospital payments to outpatient or physician office reimbursement levels.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHELSEA ARNONE | — |
| SHOSHANA KRILOW | — |
| STEVEN RIXEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.